Professional background

Dr Shah completed her medical training at Fatima Jinnah Medical College in Pakistan. She completed her haematology specialist registrar training on the UCLH rotoation and then undertook research with Professor John Porter at UCL. She was successfully awarded her MD on the relationship between non-transferrin bound iron and iron overload in sickle and thalassaemia syndromes. She became a fellow of the Royal College of Physicians in 2008.

Dr Shah was appointed consultant Haematologist at the Whittington Hospital NHS in 2004 and and has worked at University College London Hospitals, London since 2006 as an honorary consultant. She currently undertakes one clinic a week on red cell disorders at UCLH. Dr Shah has an active research programme for patients at Whittington hospital and undertakes clinical trials on thalassaemia and sickle cell disorders. Dr Shah has published extensively in peer reviewed Jounals as part of her research work.

Dr Shah has been a member of the clinical reference group for haemoglobinopathies since 2013. She is the current Chair of the National Haemoglobiopathy Registry which records information on patients with haemoglobinopathies and rare anaemias in order to improve clinical care in the UK. In this capacity Dr Shah is also sits on the National haemoglobinopathy Panel both as an expert and as lead for the NHR. Dr Shah is also the current Chair of the UK Forum on haemoglobin Disorders (2019) and was treasurer from 2012. As a result of this Dr Shah is extensively involved in improving clinical care and access to expert care of patients in the UK.

Research interests

Thalassaemia syndromes and sickle cell disease, iron overload

Languages spoken

Urdu, Pubjabi, Hindi


Last 5 years:

M Domenica Cappellini et al: BELIEVE Investigators; A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent ?-Thalassemia, N Engl J Med. 2020 Mar 26;382(13):1219-1231

Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in ?-thalassemia. Blood Rev. 2019 Sep;37. Epub 2019 Jul 6.

Vosper J, Evangeli M, Porter JB, Shah F. Psychological Factors Associated with Episodic Chelation Adherence in Thalassemia Hemoglobin. 2018 Jan;42(1):30-36.

Vlachodimitropoulou E, Thomas A, Shah F, Kyei-Mensah A. Pregnancy and iron status in ?-thalassaemia major and intermedia: six years' experience in a North London Hospital. J Obstet Gynaecol. 2018 May;38(4):567-570.

Zonoozi S, Barnard M, Prescott E, Jones R, Shah FT, Tzoulis P. Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series. Mediterr J Hematol Infect Dis. 2017 Jan 1;9(1):e2017004. doi: 10.4084/MJHID.2017.004. eCollection 2017.

Sado DM, Maestrini V, Piechnik SK, Banypersad SM, White SK, Flett AS, Robson MD, Neubauer S, Ariti C, Arai A, Kellman P, Yamamura J, Schoennagel BP, Shah F, Davis B, Trompeter S, Walker M, Porter J, Moon JC. Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload. J Magn Reson Imaging. 2015 Jun;41(6):1505-11.

Tzoulis P, Ang AL, Shah FT, Berovic M, Prescott E, Jones R, Barnard M. Prevalence of low bone mass and vitamin D deficiency in ?-thalassemia major. Hemoglobin. 2014;38(3):173-8. Epub 2014 Apr 24.